38 related articles for article (PubMed ID: 38511246)
1. Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?
Bohley M; Leroux JC
Adv Sci (Weinh); 2024 Jun; ():e2400843. PubMed ID: 38884149
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
[TBL] [Abstract][Full Text] [Related]
3. [Advances in the studies of pancreatic kininogenase in male reproduction].
Wang DD; Sun DL; Jin BF
Zhonghua Nan Ke Xue; 2021 May; 27(5):445-449. PubMed ID: 34914321
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of salcaprozate sodium and its significance in enhancing pancreatic kininogenase absorption performance.
Lv Z; Luo QD; Tang ZY; Lv XH; Wu T; Huang LK; Tang C
Pharmacol Res Perspect; 2024 Apr; 12(2):e1186. PubMed ID: 38511246
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
[TBL] [Abstract][Full Text] [Related]
7. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
Castelli MC; Wong DF; Friedman K; Riley MG
Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
[TBL] [Abstract][Full Text] [Related]
9. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
10. Uptake and cellular effects of PE, PP, PET and PVC microplastic particles.
Stock V; Laurisch C; Franke J; Dönmez MH; Voss L; Böhmert L; Braeuning A; Sieg H
Toxicol In Vitro; 2021 Feb; 70():105021. PubMed ID: 33049312
[TBL] [Abstract][Full Text] [Related]
11. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist.
Buckley ST; Bækdal TA; Vegge A; Maarbjerg SJ; Pyke C; Ahnfelt-Rønne J; Madsen KG; Schéele SG; Alanentalo T; Kirk RK; Pedersen BL; Skyggebjerg RB; Benie AJ; Strauss HM; Wahlund PO; Bjerregaard S; Farkas E; Fekete C; Søndergaard FL; Borregaard J; Hartoft-Nielsen ML; Knudsen LB
Sci Transl Med; 2018 Nov; 10(467):. PubMed ID: 30429357
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development.
Fredlund L; Winiwarter S; Hilgendorf C
Mol Pharm; 2017 May; 14(5):1601-1609. PubMed ID: 28329446
[TBL] [Abstract][Full Text] [Related]
13. Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
[TBL] [Abstract][Full Text] [Related]
14. Improved performance of antigen-HRP conjugate-based immunoassays after the addition of anti-HRP antibody and application of a liposomal chemiluminescence marker.
Dotsikas Y; Loukas YL
Anal Sci; 2012; 28(8):753-7. PubMed ID: 22878629
[TBL] [Abstract][Full Text] [Related]
15. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium.
Ferruzza S; Rossi C; Scarino ML; Sambuy Y
Toxicol In Vitro; 2012 Dec; 26(8):1252-5. PubMed ID: 22265977
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
